192 related articles for article (PubMed ID: 12941923)
1. Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus.
Brussel A; Sonigo P
J Virol; 2003 Sep; 77(18):10119-24. PubMed ID: 12941923
[TBL] [Abstract][Full Text] [Related]
2. Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction.
Van Maele B; De Rijck J; De Clercq E; Debyser Z
J Virol; 2003 Apr; 77(8):4685-94. PubMed ID: 12663775
[TBL] [Abstract][Full Text] [Related]
3. Development of a droplet digital polymerase chain reaction assay for the sensitive detection of total and integrated HIV-1 DNA.
Yuan L; Liu Z; Zhang X; Wei F; Guo S; Guo N; Liu L; Ma Z; Ji Y; Wang R; Lu X; Li Z; Xia W; Wu H; Zhang T; Su B
Chin Med J (Engl); 2024 Mar; 137(6):729-736. PubMed ID: 38433332
[TBL] [Abstract][Full Text] [Related]
4. Impact of the DNA extraction method on 2-LTR DNA circle recovery from HIV-1 infected cells.
Badralmaa Y; Natarajan V
J Virol Methods; 2013 Oct; 193(1):184-9. PubMed ID: 23773807
[TBL] [Abstract][Full Text] [Related]
5. Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR.
Liszewski MK; Yu JJ; O'Doherty U
Methods; 2009 Apr; 47(4):254-60. PubMed ID: 19195495
[TBL] [Abstract][Full Text] [Related]
6. Alu-LTR real-time nested PCR assay for quantifying integrated HIV-1 DNA.
Brussel A; Delelis O; Sonigo P
Methods Mol Biol; 2005; 304():139-54. PubMed ID: 16061972
[TBL] [Abstract][Full Text] [Related]
7. Chromatin organization at the nuclear pore favours HIV replication.
Lelek M; Casartelli N; Pellin D; Rizzi E; Souque P; Severgnini M; Di Serio C; Fricke T; Diaz-Griffero F; Zimmer C; Charneau P; Di Nunzio F
Nat Commun; 2015 Mar; 6():6483. PubMed ID: 25744187
[TBL] [Abstract][Full Text] [Related]
8. Accurate episomal HIV 2-LTR circles quantification using optimized DNA isolation and droplet digital PCR.
Malatinkova E; Kiselinova M; Bonczkowski P; Trypsteen W; Messiaen P; Vermeire J; Verhasselt B; Vervisch K; Vandekerckhove L; De Spiegelaere W
J Int AIDS Soc; 2014; 17(4 Suppl 3):19674. PubMed ID: 25397424
[TBL] [Abstract][Full Text] [Related]
9. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.
Ho YC; Shan L; Hosmane NN; Wang J; Laskey SB; Rosenbloom DI; Lai J; Blankson JN; Siliciano JD; Siliciano RF
Cell; 2013 Oct; 155(3):540-51. PubMed ID: 24243014
[TBL] [Abstract][Full Text] [Related]
10. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.
Chomont N; El-Far M; Ancuta P; Trautmann L; Procopio FA; Yassine-Diab B; Boucher G; Boulassel MR; Ghattas G; Brenchley JM; Schacker TW; Hill BJ; Douek DC; Routy JP; Haddad EK; Sékaly RP
Nat Med; 2009 Aug; 15(8):893-900. PubMed ID: 19543283
[TBL] [Abstract][Full Text] [Related]
11. POLE3 is a repressor of unintegrated HIV-1 DNA required for efficient virus integration and escape from innate immune sensing.
Thenin-Houssier S; Machida S; Jahan C; Bonnet-Madin L; Abbou S; Chen HC; Tesfaye R; Cuvier O; Benkirane M
Sci Adv; 2023 Nov; 9(44):eadh3642. PubMed ID: 37922361
[TBL] [Abstract][Full Text] [Related]
12. BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines.
Moll GM; Swenson CL; Yuzbasiyan-Gurkan V
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766260
[TBL] [Abstract][Full Text] [Related]
13. Measuring Human Immunodeficiency Virus Reservoirs: Do We Need to Choose Between Quantity and Quality?
Roux H; Chomont N
J Infect Dis; 2024 Mar; 229(3):635-643. PubMed ID: 37665978
[TBL] [Abstract][Full Text] [Related]
14. A scalable workflow to test "shock and kill" therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo.
Procopio FA; Savarino A; Shytaj IL
STAR Protoc; 2023 Apr; 4(2):102253. PubMed ID: 37097819
[TBL] [Abstract][Full Text] [Related]
15. CD4
Albalawi YA; Narasipura SD; Olivares LJ; Al-Harthi L
J Virol; 2022 Aug; 96(15):e0080422. PubMed ID: 35852355
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance.
Martínez-Román P; Crespo-Bermejo C; Valle-Millares D; Lara-Aguilar V; Arca-Lafuente S; Martín-Carbonero L; Ryan P; de Los Santos I; López-Huertas MR; Palladino C; Muñoz-Muñoz M; Fernández-Rodríguez A; Coiras M; Briz V; On Behalf Of The Covihep Network
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806864
[TBL] [Abstract][Full Text] [Related]
17. Ex Vivo Differentiation of Resting CD4+ T Lymphocytes Enhances Detection of Replication Competent HIV-1 in Viral Outgrowth Assays.
Wonderlich ER; Reece MD; Kulpa DA
Methods Mol Biol; 2022; 2407():315-331. PubMed ID: 34985673
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stromal Cells: a Possible Reservoir for HIV-1?
Kallmeyer K; Ryder MA; Pepper MS
Stem Cell Rev Rep; 2022 Apr; 18(4):1253-1280. PubMed ID: 34973144
[TBL] [Abstract][Full Text] [Related]
19. Neochlorogenic acid: an anti-HIV active compound identified by screening of Cortex Mori [
Li J; Dou L; Chen S; Zhou H; Mou F
Pharm Biol; 2021 Dec; 59(1):1517-1527. PubMed ID: 34714196
[TBL] [Abstract][Full Text] [Related]
20. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.
Vigón L; Martínez-Román P; Rodríguez-Mora S; Torres M; Puertas MC; Mateos E; Salgado M; Navarro A; Sánchez-Conde M; Ambrosioni J; Cervero M; Wyen C; Hoffmann C; Miró JM; Alcamí J; Podzamczer D; García-Gutiérrez V; Martínez-Picado J; Briz V; Rosa López-Huertas M; Planelles V; Coiras M;
Biochem Pharmacol; 2021 Oct; 192():114666. PubMed ID: 34186065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
